In 2016, the International Consortium for Personalised Medicine (ICPerMed) was established by over 30 European members in collaboration with the European Commission. IHU PRISM, the first national center for precision medicine in oncology in France, emerged from a partnership between ICPerMed and Institut Hospitalo-Universitaire. This initiative, focusing on cancer care, received a significant €30 million […]